IL25<sup>+</sup> macrophages are a key determinant of treatment resistance of IL17RB<sup>+</sup> breast cancer.

IL25⁺ macrophages are a key determinant of treatment resistance of IL17RB⁺ breast cancer.

Ozaki, Yukinori; Kinowaki, Keiichi; Kawabata, Hidetaka; Kudo-Saito, Chie.

Afiliação

Ozaki Y; Department of Immune Medicine, National Cancer Center Research Institute Tokyo 104-0045, Japan.
Kinowaki K; Department of Medical Oncology, Toranomon Hospital Tokyo 105-8470, Japan.
Kawabata H; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo 135-8550, Japan.
Kudo-Saito C; Department of Pathology, Toranomon Hospital Tokyo 105-8470, Japan.

Am J Cancer Res ; 13(10): 4931-4943, 2023.

Article em En | MEDLINE | ID: mdl-37970362